The effect of chronic obstructive pulmonary disease on the clinical and functional state of myocardium in patients with ischemic heart disease
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: the goal of the study was to investigate clinically functional characteristics of the myocardium in patients with chronic obstructive pulmonary disease combined with ischemic heart disease.
Materials and methods. We examined 68 patients with chronic obstructive lung disease and ischemic heart disease. The 1st group included 22 patients with ischemic heart disease with stable angina of II–III functional class; the 2nd group included 22 patients with chronic obstructive pulmonary disease; the 3rd one – 24 subjects with comorbidity. All the patients were undergone clinical examination. Also, investigation of the distance at 6-minute walk, daily electrocardiogram monitoring, respiratory function test, pulse oximetry, Doppler were performed.
Results. Based on the obtained data, at subjects with comorbid pathology at 73,2% of cases a characteristic feature of angina clinical course was the typical pain syndrome together with shortness of breath and palpitation. Lipid profile in patients with the comorbid pathology changes in lipid metabolism matched type IIA dyslipidemia A. Fredrikson classification. The data analysis of daily monitoring of the electrocardiogram was observed more frequent presence of arrhythmias in patients with combined pathology; also it was noted a significantly greater number of episodes of silent ischemia, which was confirmed by the decrease of the integral parameter of the functional status of patients during the tests with the 6-minute walk and the by the results of the analysis of blood gas composition.
Conclusion. Thus, in patients with comorbidity typical pain accompanied by shortness of breath and palpitations, more frequently registered the presence of various arrhythmias and painless form of ischemia, as well as more expressed systolic dysfunction of the left ventricle due to the presence of mixed (circulatory, hypoxic and tissue) type of hypoxia.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Алибек К. Инфекция как фактор риска развития атеросклероза: современные представления и перспективы лечения / К. Алибек, А. Пашкова // Лікарська справа. – 2007. – № 3. – С. 31–35.
Баздырев Е.Д. Сердечно-сосудистые факторы риска у пациентов с хронической обструктивной болезнью легких / Е.Д. Баздырев, Е.Б. Герасимова, О.М. Поликутина [и др.] // Клиницист. – 2014. – № 1. – С. 22–27. https://doi.org/10.17650/1818-8338-2014-1-22-27
Боев С.С. Сочетание хронической обструктивной болезни легких и ишемической болезни сердца. Вопросы рациональной терапии / С.С. Боев, Н.Я. Доценко, И.А. Шехунова, В.О. Дедова //Terapia український медичний вісник. – 2015. – № 2 (95). – С. 24–28.
Григорьева Н.Ю. Место хронической обструктивной болезни легких в развитии сердечно-сосудистого континуума. / Н.Ю. Григорьева, А.Н. Кузнецов, Е.Г. Шарабрин // Сердце. – 2012. – № 11 (2). – С. 120–125.
Павленко В.И. Особенности проявления безболевой ишемии миокарда у больных хронической обструктивной болезнью легких / В.И. Павленко, С.В. Нарышкина // Кардиология. – 2012. – № 2. – С. 31–36.
Поликутина О.М. Впервые выявленная хроническая обструктивная болезнь легких и ее клиническая значимость у больных с инфарктом миокарда с подъемом сегмента ST / О.М. Поликутина, Ю.С. Слепынина, Е.Д. Баздырев [и др.] // Тер. Архив. – 2014. – № 86 (3) – С. 14–9.
Libby P. Inflammation and its resolution as determinants of acute coronary syndromes / P. Libby, I. Tabas, E. Fisher. – Vol. 114 (12). – Р. 1867–1879. https://doi.org/10.1161/CIRCRESAHA.114.302699
Pinol-Ripoll G. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. / G. Pinol-Ripoll, I. de la Puerta, S. Santos [et al.] // Cerebrovasc. Dis. – 2008. – Vol. 26. – Р. 339–347. https://doi.org/10.1159/000151636
Watson C. Role of Chlamydia pneumonia in atherosclerosis / C. Watson, J. Nicholas // Clinical Science. – 2008. – Vol. 14 (8). – Р. 509–531. https://doi.org/10.1042/CS20070298
Watz H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation / H. Watz, B. Waschki, T. Meyer [et al.] //Chest. – 2010. – Vol. 138, № 1. – Р. 32–38. https://doi.org/10.1378/chest.09-2810